Effects of alpha-lipoic acid on microcirculation in patients with peripheral diabetic neuropathy

Experimental and Clinical Endocrinology and Diabetes

Volumn 108, Issue 3, 2000, Pages 168-174

  Haak, E ^a,b   Usadel, K H ^a   Kusterer, K ^a   Amini, P ^a   Frommeyer, R ^a   Tritschler, H J ^a   Haak, T ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Alpha lipoic acid; Capillaroscopy; Diabetic neuropathy; Microcirculation

Indexed keywords

THIOCTIC ACID;

ADULT; AGED; ARTICLE; BLOOD FLOW; CAPILLAROSCOPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; FEMALE; HUMAN; HYPEREMIA; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; PRIORITY JOURNAL; SKIN TEMPERATURE;

ANTIOXIDANTS; BLOOD FLOW VELOCITY; CAPILLARIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; HEMATOCRIT; HEMODYNAMIC PROCESSES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; NEUROLOGIC EXAMINATION; PLATELET COUNT; SMOKING; THIOCTIC ACID; VIBRATION;

EID: 0034107946     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-7739     Document Type: Article

References (30)

1. Biewenga GP, Haenen GR, Bast A: The pharmacology of the antioxidant lipoic acid. General Pharmacology 29: 315-331, 1997
2. Bollinger A, Butti P, Barras JP, Trachsler H, Siegenthaler W: Red blood cell velocity in nailfold capillaries of man measured by a television microscopy technique. Microvasc Res 7: 61-72, 1974
3. Bollinger A, Fagrell B: Clinical capillaroscopy - A guide to its use in clinical research and practice. Lewitson, Hogrefe & Huber, 1990
4. Cameron NE, Cotter MA, Horrobin DH, Tritschler HJ: Effects of alpha-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids. Diabetologia 41: 390-399, 1998
5. Cameron NE, Cotter MA: Interaction between oxidative stress and gamma-linolenic acid in impaired neurovascular function of diabetic rats. Am J Physiol 271: E471-E476, 1996
6. Cameron NE, Cotter MA: Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes 46: S31-S37, 1997
7. Collier A, Rumley A, Rumley AG, Paterson JR, Leach JP, Lowe GD, Small M: Free radical activity and hemostatic factors in type 2 diabetes mellitus patients with and without microalbuminuria. Diabetes 41: 909-913, 1992
8. Fagrell B, Östergren J: Reactive hyperemia response in human skin capillaries after varying occlusion duration. Bibl Anat 20: 692-696, 1981
9. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxion of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980
10. Gasser P: Video-nailfold-microscopy and local cold test: Morphological and hemdynamic correlates in 124 healthy subjects. VASA 20: 244-251, 1991
11. Greene DA, Simva AAF, Stevens MJ, Feldmann EL, Lattimer SA: Complications: neuropathy, pathogenetic considerations. Diabetes care 15: 1902-1925, 1992
12. Jung F, Wappler M, Nüttgens HP, Kiesewetter H, Wolf S, Müller G: Video capillary microscopy: Determination of geometrical and dynamic parameters. Biomed Tech 32: 204-213, 1987
13. Kahler W, Kuklinski B, Rühlmann Ch, Plötz Ch: Diabetes mellitus - eine mit freien Radikalen assoziierte Erkrankung. Resultate einer adjuvanten Antioxidantiensupplementation. Innere Medizin 48: 223-232, 1993
14. Kihara M, Low PA: Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy. Exp Neurology 132: 180-185, 1995
15. Klein W: Die Behandlung der Neuropathia diabetica mit oralen Gaben von Alpha-Liponsäure. Münch Med Wschr 117: 22, 1975
16. Luft D: Therapeutische Strategien bei der diabotischen Neuropathie: Pathogenetisch begründbare Therapieansätze der peripheren, sensiblen, symmetrischen Neuropathie. Med Klin 91: 295-305, 1996
17. Nagamatsu M, Nickander KK, Schmelzer JD, Raya A, Wittrock DA, Tritschler H, Low PA: Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 18: 1160-1167, 1995
18. Packer L, Tritschler HJ, Wessel K: Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radical Biology and Medicine 22: 359-378, 1997
19. Reschke B, Zeuzem R, Rosak C, Petzoldt R, Althoff PH, Ulrich H, Schöffling K: Hochdosierte Langzeitbehandlung mit Thioctsäure bei der diabetischen Polyneuropathie - Ergebnisse einer kontrollierten, randomisierten Studie unter Berücksichtigung der autonomen Neuropathie. In: Borbe H. O., Ulrich H. (Hrsg.): Neue biochemische, pharmakologische und klinische Erkenntnisse der Thioctsäure. pmi-Verlag. Frankfurt 318-334, 1989
20. Richardson D: Effects of tobacco smoke inhalation on capillary blood flow in human skin. Arch Environ Health 42: 19-27, 1987
21. Rubanyi GM, Romero C, Vanhoutte PM: Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 250: 1115-1119, 1986
22. Sachse G, Willms B: Efficacy of thioctic acid in the therapy of peripheral diabetic neuropathy. Horm Metab Res 9: 105-108, 1980
23. Stevens MJ, Feldmann EL, Greene DA: The aetiology of diabetic neuropathy: the combined roles of metabolic and vascular defects. Diab Med 12: 566-579, 1995
24. Tesfamariam B, Cohen RA: Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol 263: 321-326, 1992
25. Yoshida K, Hirokawa J, Tagami S, Kawakami Y, Urata Y, Kondo T: Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and efflux. Diabetologia 38: 201-210, 1995
26. Ziegler D, Hanefeld M, Ruhnau KJ, Meißner HP, Lobisch M, Schütte K, Gries FA: The ALADIN Study Group: Treatment of symptomatic diabetic peripheral neuropathy with the antioxidant α-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia 38: 1425-1433, 1995
27. Ziegler D, Mayer P, Gries F: Evaluation of thermal, pain, and vibration sensation thresholds in newly diagnosed Type 1 diabetic patients. J of Neurology, Neurosurgery, and Psychiatry 51: 1402-1424, 1988
28. Ziegler D, Mayer P, Mühlen H, Gries FA: Effekte einer Therapie mit Alpha-Liponsäure gegenüber Vitamin B1 bei der diabetischen Neuropathie. Diabetes u. Stoffw 2: 443-448, 1993
29. Ziegler D, Mayer P, Wiefels K, Gries F: Assessment of small and large fiber function in long-term type 1 (insulin-dependent) diabetic patients with and without painful neuropathy. Pain 34: 1-10, 1988
30. Ziegler D: Diagnosis, staging, and epidemiology of diabetic peripheral neuropathy. Diab Nutr Metab 7: 342-348, 1994